Cargando…
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and u...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878156/ https://www.ncbi.nlm.nih.gov/pubmed/35207239 http://dx.doi.org/10.3390/jcm11040968 |
_version_ | 1784658595165503488 |
---|---|
author | Mantovani, Alessandro Dalbeni, Andrea Beatrice, Giorgia Cappelli, Davide Gomez-Peralta, Fernando |
author_facet | Mantovani, Alessandro Dalbeni, Andrea Beatrice, Giorgia Cappelli, Davide Gomez-Peralta, Fernando |
author_sort | Mantovani, Alessandro |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and up to 70% of patients with T2DM. Over the last few decades, it clearly emerged that NAFLD is a “multisystemic disease” and that the leading cause of death among patients with NAFLD is cardiovascular disease (CVD). Indeed, several observational studies and some meta-analyses have documented that NAFLD, especially its advanced forms, is strongly associated with fatal and non-fatal cardiovascular events, as well as with specific cardiac complications, including sub-clinical myocardial alteration and dysfunction, heart valve diseases and cardiac arrhythmias. Importantly, across various studies, these associations remained significant after adjustment for established cardiovascular risk factors and other confounders. Additionally, several observational studies and some meta-analyses have also reported that NAFLD is independently associated with specific microvascular conditions, such as chronic kidney disease and distal or autonomic neuropathy. Conversely, data regarding a potential association between NAFLD and retinopathy are scarce and often conflicting. This narrative review will describe the current evidence about the association between NAFLD and the risk of macro- and microvascular manifestations of CVD, especially in patients with T2DM. We will also briefly discuss the biological mechanisms underpinning the association between NAFLD and its advanced forms and macro- and microvascular CVD. |
format | Online Article Text |
id | pubmed-8878156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88781562022-02-26 Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes Mantovani, Alessandro Dalbeni, Andrea Beatrice, Giorgia Cappelli, Davide Gomez-Peralta, Fernando J Clin Med Review Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and up to 70% of patients with T2DM. Over the last few decades, it clearly emerged that NAFLD is a “multisystemic disease” and that the leading cause of death among patients with NAFLD is cardiovascular disease (CVD). Indeed, several observational studies and some meta-analyses have documented that NAFLD, especially its advanced forms, is strongly associated with fatal and non-fatal cardiovascular events, as well as with specific cardiac complications, including sub-clinical myocardial alteration and dysfunction, heart valve diseases and cardiac arrhythmias. Importantly, across various studies, these associations remained significant after adjustment for established cardiovascular risk factors and other confounders. Additionally, several observational studies and some meta-analyses have also reported that NAFLD is independently associated with specific microvascular conditions, such as chronic kidney disease and distal or autonomic neuropathy. Conversely, data regarding a potential association between NAFLD and retinopathy are scarce and often conflicting. This narrative review will describe the current evidence about the association between NAFLD and the risk of macro- and microvascular manifestations of CVD, especially in patients with T2DM. We will also briefly discuss the biological mechanisms underpinning the association between NAFLD and its advanced forms and macro- and microvascular CVD. MDPI 2022-02-12 /pmc/articles/PMC8878156/ /pubmed/35207239 http://dx.doi.org/10.3390/jcm11040968 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mantovani, Alessandro Dalbeni, Andrea Beatrice, Giorgia Cappelli, Davide Gomez-Peralta, Fernando Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes |
title | Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes |
title_full | Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes |
title_fullStr | Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes |
title_full_unstemmed | Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes |
title_short | Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes |
title_sort | non-alcoholic fatty liver disease and risk of macro- and microvascular complications in patients with type 2 diabetes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878156/ https://www.ncbi.nlm.nih.gov/pubmed/35207239 http://dx.doi.org/10.3390/jcm11040968 |
work_keys_str_mv | AT mantovanialessandro nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes AT dalbeniandrea nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes AT beatricegiorgia nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes AT cappellidavide nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes AT gomezperaltafernando nonalcoholicfattyliverdiseaseandriskofmacroandmicrovascularcomplicationsinpatientswithtype2diabetes |